2026 Vol.44, N°3 - Table of contents
March 2026
One year in review
CER19809
2026,44,3
Pg. 0427-0437
Free to view
Systemic lupus erythematosus: one year in review 2026
G. Cascarano, D. Zucchi, C. Cardelli, M. Oliva, G. Capozzo, A. Elia, E. Silvagni, E. Elefante, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/mg0q41
G. Cascarano, D. Zucchi, C. Cardelli, M. Oliva, G. Capozzo, A. Elia, E. Silvagni, E. Elefante, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/mg0q41
Environmental Rheumatology
CER18823
2026,44,3
Pg. 0438-0451
Free to view
Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021
W. Zhang, D. Zhuang, H. Lu, Z. Lv, L. Huang, H. Du, J. Chang, M. Xiao, M. Chen, W. Ying, H. Lei, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/7dijpb
W. Zhang, D. Zhuang, H. Lu, Z. Lv, L. Huang, H. Du, J. Chang, M. Xiao, M. Chen, W. Ying, H. Lei, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/7dijpb
CER18953
2026,44,3
Pg. 0452-0461
Free to view
Red wine antioxidant properties implications in rheumatic diseases: exploring clonal variations in resveratrol and other bioactive compounds
F. Belli, F. Bandinelli, R. Bandinelli, M. Pagano
DOI: https://doi.org/10.55563/clinexprheumatol/pybjjj
F. Belli, F. Bandinelli, R. Bandinelli, M. Pagano
DOI: https://doi.org/10.55563/clinexprheumatol/pybjjj
Full Papers
CER18354
2026,44,3
Pg. 0462-0467
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort
F. Ceccarelli, M. Piga, F.R. Spinelli, I. Prevete, A. Cauli, F. Iannone, L. Coladonato, M. Govoni, A. Bortoluzzi, M. Mosca, C. Tani, A. Doria, L. Iaccarino, F. Franceschini, M. Fredi, B. Frediani, F. Bellisai, D. Rozza, A. Zanetti, G. Carrara, C.A. Scirè, G.D. Sebastiani, F. Conti
on behalf of the study group on Early SLE of the Italian Society of Rheumatology
DOI: https://doi.org/10.55563/clinexprheumatol/dagoie
F. Ceccarelli, M. Piga, F.R. Spinelli, I. Prevete, A. Cauli, F. Iannone, L. Coladonato, M. Govoni, A. Bortoluzzi, M. Mosca, C. Tani, A. Doria, L. Iaccarino, F. Franceschini, M. Fredi, B. Frediani, F. Bellisai, D. Rozza, A. Zanetti, G. Carrara, C.A. Scirè, G.D. Sebastiani, F. Conti
on behalf of the study group on Early SLE of the Italian Society of Rheumatology
DOI: https://doi.org/10.55563/clinexprheumatol/dagoie
CER18685
2026,44,3
Pg. 0468-0475
Tofacitinib attenuates IL-6-mediated endothelial tissue factor induction in vitro without affecting platelet aggregation in vivo: mechanistic insights into cardiovascular risk in rheumatoid arthritis
G. Cimmino, D. Mauro, M. Morello, G. Titolo, D. Iacono, G. Forte, A. Salzillo, M. Raimondi, F. Riccio, I. Pantano, G. De Rosa, P. Cirillo, F. Ciccia
DOI: https://doi.org/10.55563/clinexprheumatol/k0fdes
G. Cimmino, D. Mauro, M. Morello, G. Titolo, D. Iacono, G. Forte, A. Salzillo, M. Raimondi, F. Riccio, I. Pantano, G. De Rosa, P. Cirillo, F. Ciccia
DOI: https://doi.org/10.55563/clinexprheumatol/k0fdes
CER18788
2026,44,3
Pg. 0476-0484
Free to view
Modification of cardiovascular risk factors after viscosupplementation with hyaluronic acid in patients with symptomatic hip and knee osteoarthritis
A.M. García-Bravo, M.Á. Ruiz-Fernández, A. Taboada Vázquez, A. Vizcaíno-Arzola, O. Del rey-Echevarría, M. Rufino-Navarro, L. Pérez-Méndez, F.J. De león-García
DOI: https://doi.org/10.55563/clinexprheumatol/tsa1u8
A.M. García-Bravo, M.Á. Ruiz-Fernández, A. Taboada Vázquez, A. Vizcaíno-Arzola, O. Del rey-Echevarría, M. Rufino-Navarro, L. Pérez-Méndez, F.J. De león-García
DOI: https://doi.org/10.55563/clinexprheumatol/tsa1u8
CER18299
2026,44,3
Pg. 0485-0490
Free to view
GITR/GITRL interaction promotes the expansion of T helper 9 and T helper 17 in psoriatic arthritis
L. La Barbera, C. Rizzo, M. Lo Pizzo, D. Di Liberto, M.P. La Manna, L. Mohammadnezhad, F. Camarda, G. Sireci, F. Ciccia, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/31hjvf
L. La Barbera, C. Rizzo, M. Lo Pizzo, D. Di Liberto, M.P. La Manna, L. Mohammadnezhad, F. Camarda, G. Sireci, F. Ciccia, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/31hjvf
CER18832
2026,44,3
Pg. 0491-0498
Free to view
Circulating microRNAs associated with tumour necrosis factor or fibloblast-like synoviocyte predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study
Y. Hosokawa, Y. Yoshida, H. Tamai, S. Hirata, K. Ikeda, T. Miyamoto, H. Taguchi, C.-F. Kuo, K. Shin, K. Izumi, Y. Kondo, H. Yasuoka, M. Kuwana, T. Ishii, H. Kameda, T. Kojima, M. Mori, Y. Sato, W.-C. Tsai, T. Takeuchi, Y. Kaneko
Collaborator/s: Y. Okano, S. Sato, T. Gono, K. Yoshimoto, I.A. Choi, S.-H. Park, M.-Y. Weng, Y.J. Lee, J. Kim, H.J. Baek, P.-N. Hsu, C.-M. Huang, T.-T. Cheng, W.-Y. Sung
the MIRACLE study collaborators
DOI: https://doi.org/10.55563/clinexprheumatol/keymab
Y. Hosokawa, Y. Yoshida, H. Tamai, S. Hirata, K. Ikeda, T. Miyamoto, H. Taguchi, C.-F. Kuo, K. Shin, K. Izumi, Y. Kondo, H. Yasuoka, M. Kuwana, T. Ishii, H. Kameda, T. Kojima, M. Mori, Y. Sato, W.-C. Tsai, T. Takeuchi, Y. Kaneko
Collaborator/s: Y. Okano, S. Sato, T. Gono, K. Yoshimoto, I.A. Choi, S.-H. Park, M.-Y. Weng, Y.J. Lee, J. Kim, H.J. Baek, P.-N. Hsu, C.-M. Huang, T.-T. Cheng, W.-Y. Sung
the MIRACLE study collaborators
DOI: https://doi.org/10.55563/clinexprheumatol/keymab
CER18417
2026,44,3
Pg. 0499-0508
Free to view
Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical study
H. Ye, S. Liu, Y. Mei, J. Gu, M. Yang, L. Zhang, G. Wang, Z. He, F. Wu, Y. Zheng, M. Xia, B. Li, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2t27x9
H. Ye, S. Liu, Y. Mei, J. Gu, M. Yang, L. Zhang, G. Wang, Z. He, F. Wu, Y. Zheng, M. Xia, B. Li, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2t27x9
CER18966
2026,44,3
Pg. 0509-0516
Evaluating the metabolic score for insulin resistance in patients with systemic lupus erythematosus
A. Aznar-Esquivel, M. Hernández-González, M. García-González, F. Gómez-Bernal, J.C. Quevedo-Abeledo, C. Almeida-Santiago, A. Molina-Tercero, E. Heras-Recuero, A. De vera-González, A. González-Delgado, B. Tejera-Segura, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/m42g9r
A. Aznar-Esquivel, M. Hernández-González, M. García-González, F. Gómez-Bernal, J.C. Quevedo-Abeledo, C. Almeida-Santiago, A. Molina-Tercero, E. Heras-Recuero, A. De vera-González, A. González-Delgado, B. Tejera-Segura, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/m42g9r
CER18985
2026,44,3
Pg. 0517-0526
Clinical characteristics and prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: a retrospective study
Y. Shi, R. Chen, H. Sun, K. Xu, Z. Li, M. Wang, C. Shao, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/yyd4gm
Y. Shi, R. Chen, H. Sun, K. Xu, Z. Li, M. Wang, C. Shao, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/yyd4gm
CER18958
2026,44,3
Pg. 0527-0533
Free to view
Cardiac strain in patients on Janus Kinase inhibitors for rheumatic diseases: a 1-year echocardiographic study
N. Kougkas, E. Skouvaklidou, K. Tsafis, D. Deligeorgakis, V. Skepastianos, C. Adamichou, E. Papadimitriou, A. Mpitouli, M. Boutel, F. Dimitriadis, G. Spagos, I. Zarifis, T. Dimitroulas, A. Tsaousidis
DOI: https://doi.org/10.55563/clinexprheumatol/al5kv6
N. Kougkas, E. Skouvaklidou, K. Tsafis, D. Deligeorgakis, V. Skepastianos, C. Adamichou, E. Papadimitriou, A. Mpitouli, M. Boutel, F. Dimitriadis, G. Spagos, I. Zarifis, T. Dimitroulas, A. Tsaousidis
DOI: https://doi.org/10.55563/clinexprheumatol/al5kv6
CER18913
2026,44,3
Pg. 0534-0543
SHP2 inhibitor mitigated renal tubular epithelial cell injury in lupus nephritis via ERK/NF-κB pathway
Y. Chen, S. Wang, S. Tan, T. Jiang, X. Li, G. Yao, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/csqb0j
Y. Chen, S. Wang, S. Tan, T. Jiang, X. Li, G. Yao, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/csqb0j
CER18777
2026,44,3
Pg. 0544-0550
Free to view
Does different administration method of methotrexate matter in early rheumatoid arthritis? An exploratory register-based study
L. Weman, H. Salo, V. Rantalaiho, J. Huhtakangas, L. Kuusalo, P. Vähäsalo, M. Backström, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/tg7hxr
L. Weman, H. Salo, V. Rantalaiho, J. Huhtakangas, L. Kuusalo, P. Vähäsalo, M. Backström, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/tg7hxr
CER18779
2026,44,3
Pg. 0551-0558
Serum NLRC3 levels in systemic lupus erythematosus: correlation with clinical characteristics
W. Li, X. Gu, S. Liu, C. Chen, X. He, B. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/h3m8hl
W. Li, X. Gu, S. Liu, C. Chen, X. He, B. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/h3m8hl
CER19069
2026,44,3
Pg. 0559-0564
The utility of machine learning-based decision support system in referral of suspected rheumatic disease
H. Babaoğlu, H. Satiş, Y. Kavak, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/31phae
H. Babaoğlu, H. Satiş, Y. Kavak, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/31phae
CER19292
2026,44,3
Pg. 0565-0572
Free to view
Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study
U. Bakay, T. Izci Duran, O.S. Karstarli Bakay
DOI: https://doi.org/10.55563/clinexprheumatol/gniy9i
U. Bakay, T. Izci Duran, O.S. Karstarli Bakay
DOI: https://doi.org/10.55563/clinexprheumatol/gniy9i
Review
CER18776
2026,44,3
Pg. 0573-0581
Research progress of NLRP3 in immune cells of systemic lupus erythematosus
Y. Liu, Y. Wang, X. Wang, Y. Liu, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xmghi4
Y. Liu, Y. Wang, X. Wang, Y. Liu, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xmghi4
Paediatric Rheumatology
CER19248
2026,44,3
Pg. 0582-0588
Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases
M. Binda, B. Moccaldi, F. Tirelli, V. Sanetti, A. Cuberli, A. Benini, A. Meneghel, R. Ramonda, F. Zulian, E. Zanatta
DOI: https://doi.org/10.55563/clinexprheumatol/6bz7ok
M. Binda, B. Moccaldi, F. Tirelli, V. Sanetti, A. Cuberli, A. Benini, A. Meneghel, R. Ramonda, F. Zulian, E. Zanatta
DOI: https://doi.org/10.55563/clinexprheumatol/6bz7ok
Letters to the Editor
CER18960
2026,44,3
Pg. 0589-0590
Free to view
Synovial biopsy in a case of nivolumab-induced arthritis
R. Pereira Da Costa, M. Pinho, J. Patrocínio, S. Torres, C. Ferreira, J.E. Fonseca, N. Khmelinskii
DOI: https://doi.org/10.55563/clinexprheumatol/2z7vho
R. Pereira Da Costa, M. Pinho, J. Patrocínio, S. Torres, C. Ferreira, J.E. Fonseca, N. Khmelinskii
DOI: https://doi.org/10.55563/clinexprheumatol/2z7vho
CER19092
2026,44,3
Pg. 0591-0592
Free to view
Successful use of upadacitinib in a 14-year-old patient with juvenile idiopathic arthritis-associated uveitis and hidradenitis suppurativa
S. Romano, C. De Libero, E. Marrani, G. Simonini, I. Maccora
DOI: https://doi.org/10.55563/clinexprheumatol/ot85sk
S. Romano, C. De Libero, E. Marrani, G. Simonini, I. Maccora
DOI: https://doi.org/10.55563/clinexprheumatol/ot85sk